Ticker Symbol: ACST
Acasti Pharma Inc - Class A
$1.54 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Canada
Currency:
USD
Asset
Type: Common Stock
CIK:0001444192
Company Profile
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 3009, Boul. De La Concorde East
Website: https://www.acastipharma.com/
CEO: Janelle D'Alvise
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Medicinal and Botanical Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $2.43
Change:
-$0.06
(
-2.41%)
Days Range: $2.41 - $2.56
Beta: 0.10
52wk. High: $5.05
52wk. Low: $1.72
Ytd. Change -21.57%
50 Day Moving Average: $2.35
200 Day Moving Average: $2.67
Shares Outstanding: 7448033
Valuation
Market Cap: 1.8B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A